Anti-Thy-1 treated and irradiated spleen cells from (BALB/c x C57Bl/6) F1 mice infected with Plasmodium chabaudi chabaudi can transfer protection into irradiated hosts. 1993

M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
Department of Immunology, National School of Biological Sciences, Mexico DF, Mexico.

The transfer of spleen cells from (BALB/c x C57Bl/6) F1 mice recovered from a Plasmodium chabaudi chabaudi AS infection into irradiated syngeneic recipients conferred protection. Neither elimination of Thy-1+ cells nor in vitro irradiation of immune cells before transfer affected protection while both anti-Thy-1 treatment and irradiation abolished the appearance of anti-P. c. chabaudi antibodies in the recipients. Superinfection of immune spleen cell donors did not improve their capability to transfer protection which was also unaffected by anti-Thy-1 treatment. The serum of mice after one infection was only marginally protective when transferred into irradiated recipients and a second infection improved the protective activity of serum which was not further improved by six infections. The co-transfer of immune serum and immune cells did not result in any synergistic effect. On the other hand, when P. c. chabaudi AS (BALB/c x C57Bl/6) F1 infected mice were challenged with a high dose of Plasmodium yoelii 17XL at crisis, the mice were unable to control the heterologous parasite. When mice were challenged with P. yoelii 17XL several weeks after infection with P. c. chabaudi AS, a good degree of cross-protection was observed.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D007518 Isoantibodies Antibodies from an individual that react with ISOANTIGENS of another individual of the same species. Alloantibodies
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010967 Plasmodium yoelii A species of PLASMODIUM causing malaria in rodents. Plasmodium yoelius,yoelius, Plasmodium
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
May 2002, International journal of oncology,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
May 2012, Memorias do Instituto Oswaldo Cruz,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
January 1991, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
January 2022, Frontiers in immunology,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
December 1993, Scandinavian journal of immunology,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
April 2000, Parasite immunology,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
February 2018, Parasitology international,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
June 2001, Experimental parasitology,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
July 2016, Parasite immunology,
M Legorreta-Herrera, and C Fiallos-Leon, and L Cedillo-Barron, and F Martinez-Gomez, and M Foster-Cuevas, and L Favila-Castillo
April 2016, Folia parasitologica,
Copied contents to your clipboard!